Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

206 results about "Pediococcus sp." patented technology

Five-union bacteria for conditioning and improving diarrhea, constipation and irritable bowel syndrome

The invention discloses a quintuple bacterium for conditioning and improving diarrhea, constipation and irritable bowel syndrome. The quintuple bacteria comprise lactobacillus reuteri HBM11-69, pediococcus pentosaceus MPL5, lactobacillus plantarum La-10, lactobacillus rhamnosus HBM11-35 and lactobacillus casei C7-2 bacteria, and the lactobacillus rhamnosus HBM11-35, the pediococcus pentosaceus MPL5, the lactobacillus plantarum La-10, the lactobacillus rhamnosus HBM11-35 and the lactobacillus The strain is found by a Lin Junjunch Teaching Team of South China Agricultural University. The probiotic composition disclosed by the invention is mutually matched and has a synergistic effect, and the intestinal flora structure balance can be effectively recovered by improving the small intestine propulsion rate, reducing the diarrhea frequency and the like. No matter in a viable or inactivated state, the traditional Chinese medicine composition has a relatively good improvement effect on gastrointestinal discomfort such as constipation and irritable bowel syndrome. The quintuplet compound probiotics are high in safety, do not cause adverse reactions such as electrolyte imbalance and can be used for preparing medicines or health foods or foods.
Owner:JIANMA PHARM (GUANGDONG) CO LTD

Pediococcus acidilactici and application thereof

The invention discloses pediococcus acidilactici and application thereof, and relates to the technical field of microorganisms. The pediococcus acidilactici is pediococcus acidilactici Mei.1103.1, the preservation unit is China General Microbiological Culture Collection Center, the preservation number is CGMCC NO.32564, the preservation date is November 11, 2024, the preservation address is Institute of Microbiology, Chinese Academy of Sciences, No. 3, No.1 Yard, Beichen West Road, Chaoyang District, Beijing, and the preservation number is CGMCC NO.32564. The pediococcus acidilactici Mei.1103.1 is CGMCC NO.32564. The pediococcus acidilactici Mei.1103.1. The invention also provides application of the fermented dry rice flour in preparation of products for reducing uric acid, preventing / treating hyperuricemia, regulating immunity, preventing / treating kidney injury and preventing / treating fatty liver and fermented dry rice flour. The bacterium can reduce uric acid and relieve hyperuricemia; regulating blood fat; kidney and liver injuries caused by hyperuricemia are repaired; the content of volatile flavor compounds in the fermented dry rice flour is increased.
Owner:NANCHANG UNIV

Pediococcus pentosaceus CCFM1402 capable of effectively repairing skin barrier and self-fermentation metabolite of Pediococcus pentosaceus CCFM1402

The invention discloses pediococcus pentosaceus CCFM1402 capable of effectively repairing a skin barrier and a self-fermentation metabolite of the pediococcus pentosaceus CCFM1402, and belongs to the technical field of microorganisms and medicines. The pediococcus pentosaceus CCFM1402 provided by the invention has the effect of improving the skin barrier function in both external use and oral administration; the cell activity of damaged HaCaT cells and the expression of the gene level of skin barrier function protein and tight junction protein can be improved by virtue of a thallus lysate and a fermented supernatant (metagen) of the external pediococcus pentosaceus CCFM1402; and the DNFB-induced mouse skin barrier injury can be relieved in the aspects of appearance, skin barrier protein expression and the like by orally taking viable bacteria and postbiotics of the pediococcus pentosaceus CCFM1402. Therefore, the pediococcus pentosaceus CCFM1402 has a huge application prospect in preparation of external or oral medicines for repairing the skin barrier and preparation of food, health care products or cosmetics.
Owner:JIANGNAN UNIV

Preparation method and application of lactic acid bacteria metagen

The invention belongs to the technical field of microorganisms, and particularly relates to probiotic characteristics of lactic acid bacteria and a relieving effect of a metagen of the lactic acid bacteria on pulmonary fibrosis. The invention discloses pediococcus pentosaceus ZFML001, and the preservation number of the pediococcus pentosaceus ZFML001 is CCTCC (China Center for Type Culture Collection) NO: M 2024601. The invention also provides a metagen prepared from the pediococcus pentosaceus ZFML001 at the same time, and provides an application of the metagen in preparation of a medicine for relieving or assisting in treatment of pulmonary fibrosis. The invention further provides the application of the metagen in preparation of a medicine for relieving or assisting in treatment of pulmonary fibrosis.
Owner:ZHEJIANG GONGSHANG UNIVERSITY

Pediococcus acidilactici NDF12 and application thereof

The invention discloses pediococcus acidilactici NDF12 and application thereof, the pediococcus acidilactici NDF12 is preserved in Guangdong Microbial Culture Collection Center on January 8, 2025, is called GDMCC for short, and the preservation number is GDMCC NO: 65732. The invention further discloses a preparation method of the pediococcus acidilactici NDF12. The strain is derived from Chinese local traditional dairy products, phenotype and genotype safety evaluation proves that the strain is safe and non-toxic, has excellent fermentation characteristics and probiotic characteristics, and can be used as a leavening agent for producing yoghourt. The bacterial strain also has gastrointestinal fluid endurance capacity, adhesion capacity, bacteriostatic activity, antioxidant activity, cholesterol lowering activity and blood sugar lowering activity, and has great application prospects in the fields of foods, medicines, feeds and the like.
Owner:SOUTH CHINA UNIV OF TECH

Pediococcus acidilactici XZ106 and application thereof

The invention relates to pediococcus acidilactici XZ106, which is classified and named as pediococcus acidilactici, and is preserved in the China General Microbiological Culture Collection Center (CGMCC), the preservation number is CGMCC No.30094, the preservation date is March 22, 2024, and the preservation address is No.3, Yard 1, Beichen West Road, Chaoyang District, Beijing. The pediococcus acidilactici XZ106 can (1) relieve insulin resistance, regulate insulin and glucagon secretion and improve liver gluconeogenesis, so that diabetes hyperglycemia is improved; (2) weight gain, fat accumulation and liver lipid accumulation of obese mice are inhibited, glycolipid metabolism disorder of the mice is improved, and the composition has excellent effects of reducing fat and relieving obesity; (3) the level of IL-10 can be remarkably improved, and the anti-inflammatory ability of mice is improved; (4) vascular injury is reduced, so that diabetic complications and various cardiovascular diseases of atherosclerosis are prevented.
Owner:SOUTHWEST UNIV

Pediococcus acidilactici JW-015 as well as selenium-rich microbial inoculum and application thereof

The invention discloses pediococcus acidilactici JW-015 as well as a selenium-rich microbial inoculum and application thereof, and belongs to the technical field of biology. According to the invention, a strain of pediococcus JW-015 which not only can be enriched with inorganic selenium, but also has oxidation resistance and ethanol tolerance is screened out, and the pediococcus JW-015 has huge potential and application value in the aspect of developing hangover-alleviating related probiotic health-care foods and medicines.
Owner:JIANGNAN UNIV

Preparation method of glucose fermentation product with bacteriostatic activity

The invention relates to the technical field of microbial fermentation, in particular to a preparation method of a glucose fermentation product with bacteriostatic activity, which comprises the following steps: (1) inoculating a lactococcus lactis subsp. Lactis seed solution into a glucose-containing fermentation culture solution, and fermenting to obtain a first fermentation solution; (2) inoculating a pediococcus acidilactici seed solution into the first fermentation liquor, supplementing glucose, and fermenting to obtain second fermentation liquor; and (3) adjusting the pH value of the second fermentation liquor to be acidic, filtering, concentrating, and spray-drying to obtain the glucose fermentation product. According to the invention, the characteristic that organic acids and bacteriocin generated by lactococcus lactis subsp. Lactis and pediococcus acidilactici are different in types is fully utilized, metabolites of the two bacteria are obtained at the same time by adopting a sequential sequence type fermentation mode, and the metabolites of the lactococcus lactis subsp. Lactis are converted by pediococcus acidilactici, so that a new substance with bacteriostatic activity is obtained; the antibacterial activity is improved. Meanwhile, the problem of nutrition competition caused by mixed culture of the two bacteria is avoided, and the fermentation efficiency is improved.
Owner:YOTA BIO-ENG CO LTD

Pediococcus acidilactici N67-2 and application thereof in preparing rare ginsenoside by fermenting and converting ginsenoside Rg1

The invention discloses pediococcus acidilactici N67-2 and application of the pediococcus acidilactici N67-2 in preparing rare ginsenoside by fermenting and converting ginsenoside Rg1, and belongs to the field of probiotic fermentation, the pediococcus acidilactici N67-2 is preserved in the China Center for Type Culture Collection on September 18, 2024, and the preservation number is CCTCC NO: M 20241998. According to the invention, ginsenoside Rg1 is used as a raw material, and the rare ginsenosides 20 (R)-Rh1, 20 (S)-Rh1, 20 (S)-Rh4 and Rk3 are prepared by fermentation and conversion of pediococcus acidilactici N67-2. After fermentation, the ginsenoside monomer Rg1 can be completely converted, and the method has the advantages of mild reaction, environmental protection, low cost and high conversion product content. The invention provides a new way for the preparation of rare ginsenosides 20 (R)-Rh1, 20 (S)-Rh1, Rh4 and Rk3.
Owner:JILIN AGRICULTURAL UNIV

Pediococcus pentosaceus producing novel type IIa bacteriocin, its application and construction of secretory engineered bacteria

The present invention provides a Pediococcus pentosaceus ( Pediococcus pentosus ) strain ZPP083, which is deposited with the General Microbiology Center of the China National Center for Microbiological Culture Collection under the CGMCC No. 31944. The Pediococcus pentosaceus provided by the present invention has a strong antibacterial effect and produces a novel Class IIa bacteriocin with acid, heat, and protease resistance. The present invention also constructs a genetically engineered bacterium using this bacteriocin, increasing its expression.
Owner:BEIJING ACADEMY OF AGRICULTURE & FORESTRY SCIENCES

Lactic acid bacteria capable of reducing fat, resisting inflammation and reducing blood sugar and application of lactic acid bacteria

PendingCN119842551ABacteriaMetabolism disorderBiotechnologyBeta-cell Function
The invention relates to a lactic acid bacterium capable of reducing fat, resisting inflammation and reducing blood sugar, which is classified and named as pediococcus acidilactici XJ335, and is preserved in the China General Microbiological Culture Collection Center (CGMCC), the preservation number is CGMCC No.30093, the preservation date is March 22, 2024, and the preservation address is No.3, Yard 1, Beichen West Road, Chaoyang District, Beijing. The strain can achieve the fat reducing effect by adjusting the abundance of intestinal flora; the levels of IL-6 and TNF-alpha in serum of diabetic mice are remarkably improved through regulation, so that the anti-inflammatory effect is achieved; various cardiovascular diseases of atherosclerosis are prevented by adjusting the levels of TC, TG, HDL-C and LDL-C; by reducing FINS and HOMA-IR levels and improving HOMA-IS, HOMA-beta and QUICKI value levels, insulin resistance of a body is reduced, insulin sensitivity and pancreas islet beta cell functions of the body are improved, gene expression related to blood sugar regulation is regulated, and an excellent blood sugar reducing effect is achieved in the body.
Owner:SOUTHWEST UNIV

Uric acid reducing probiotics based on rapid and high-throughput screening of bombyx mori and application of uric acid reducing probiotics

The invention relates to uric acid reducing probiotics obtained by high-throughput screening based on a silkworm model, in particular to a strain SWU-MY69, which is classified and named as Pediococcus pentosaceus, is preserved in China General Microbiological Culture Collection Center (CGMCC), has a preservation number of CGMCC No.31926, and is preserved in September 10, 2024. The pediococcus pentosaceus SWU-MY69 screened through a bombyx mori model has an excellent uric acid reducing effect, the inhibition rates of bacterial suspension, contents and metabolites of the strain on xanthine oxidase in vitro are all 80% or above, and the pediococcus pentosaceus SWU-MY69 also has an excellent inhibition effect on xanthine oxidase in vivo; uric acid in hemolymph is remarkably reduced, excretion of uric acid by intestinal tracts is promoted, and therefore the concentration of uric acid in serum is reduced, and burdens of kidneys and livers are reduced.
Owner:SOUTHWEST UNIV

Pediococcus acidilactici with acid resistance, cholate resistance and bacteriostatic activity and application thereof

The invention belongs to the technical field of probiotics, and particularly relates to pediococcus acidilactici with acid resistance, bile salt resistance and antibacterial activity and application of the pediococcus acidilactici. The pediococcus acidilactici TR19 has the preservation number of CGMCC NO.31330 and is classified and named as pediococcus acidilactici according to microorganisms. The strain has good acid resistance and bile salt resistance, and can be used for preparing probiotics for preventing and treating bacteria. Meanwhile, the strain has a relatively strong bacteriostatic effect on escherichia coli, bacillus cereus, staphylococcus aureus and salmonella typhimurium, in addition, the strain has a relatively good degradation capability on nitrite and cholesterol, and the applicability is relatively strong.
Owner:WEIHAI ZIGUANG SCI & TECH PARK CO LTD +1

Application of pediococcus pentosaceus strain A20001 in preparation of product for improving memory concentration and anxiety behavior

The invention provides an application of a pediococcus pentosaceus strain A20001 in preparation of a product for improving memory concentration and anxiety and depression behaviors, and belongs to the technical field of biological medicines. Animal experiments show that the pediococcus pentosaceus strain A20001 has the functions of resisting anxiety behavior, resisting depression, improving cognitive function and improving memory concentration. Therefore, the invention provides the application of the pediococcus pentosaceus strain A20001 in the preparation of the medicine for preventing and / or treating the anxiety disorder, the depression or the cognitive impairment and improving the memory, and further provides the application of the pediococcus pentosaceus strain A20001 in the preparation of the medicine for preventing and / or treating the anxiety disorder, the depression or the cognitive impairment.
Owner:AIAGE LIFE SCI CORP LTD +1

Pediococcus pentosaceus metagen and application thereof in resisting oxidative inflammation and improving intestinal flora

The invention relates to the technical field of microbial preparations, and discloses a pediococcus pentosaceus metagen and application of the pediococcus pentosaceus metagen in resisting oxidative inflammation and improving intestinal flora, and the pediococcus pentosaceus metagen is a preparation with a substance obtained by inactivating pediococcus pentosaceus CQFP202447 as an active ingredient. The preservation number of the pediococcus pentosaceus CQFP202447 is CGMCC (China General Microbiological Culture Collection Center) NO.29615. The pediococcus The pediococcus pentosaceus metagen disclosed by the invention has a remarkable effect in the aspects of resisting oxidative inflammation and improving intestinal flora. The unique biological activity of the pediococcus pentosaceus CQFP202447 not only comes from the excellent characteristics of the pediococcus pentosaceus CQFP202447, but also benefits from the special conversion after high-temperature inactivation treatment, so that the active ingredients of the pediococcus pentosaceus CQFP202447 are more stable and are easily absorbed and utilized by a human body.
Owner:CHONGQING PAIBILE TECHNOLOGY CO LTD

Screening of pediococcus acidilactici and application of pediococcus acidilactici in reducing allergenicity of whey and improving flavor

The invention discloses pediococcus acidilactici screening and application of pediococcus acidilactici in reducing allergenicity of whey and improving flavor, and belongs to the technical field of whey processing. The invention provides a Pediococcus acidilactici BC37, and the preservation number of the Pediococcus acidilactici BC37 is GDMCC No: 66262. The Pediococcus acidilactici BC37 can be used for preparing a Pediococcus acidilactici strain. When the pediococcus acidilactici BC37 is used for preparing the fermented whey, beta-lactoglobulin and lactose in the whey can be effectively degraded, and the degradation rates respectively reach 49.93% and 15.74%; meanwhile, after whey is fermented by the pediococcus acidilactici BC37, high-content flavor substances such as furfural, butyric acid and ethyl caprate are generated. Therefore, the pediococcus acidilactici BC37 provided by the invention has a great industrial application prospect in preparation of fermented whey products with low sensitization and unique flavor.
Owner:SHANGHAI ZIQUAN BEVERAGE INDUSTRY CO LTD

A *Pediococcus pentosaceus* strain SUN02 with acetylcholinesterase inhibitory activity and its application

This invention belongs to the field of microbial technology, specifically relating to a strain of *Pediococcus pentosaceus* SUN02 with acetylcholinesterase inhibitory activity and its applications. This *Pediococcus pentosaceus* SUN02 is deposited at the China General Microbiological Culture Collection Center (CGMCC) with accession number CGMCC No. 29705. The *Pediococcus pentosaceus* SUN02 provided by this invention exhibits strong acid and bile salt resistance, good tolerance in simulated gastric and intestinal fluids, and can successfully reach the human intestine. *Pediococcus pentosaceus* SUN02, in its bacterial suspension and inactivated cells, possesses strong acetylcholinesterase inhibitory activity, produces γ-aminobutyric acid (GABA), and has antioxidant and other probiotic functions. Its application in probiotic products may help improve Alzheimer's disease, enhance learning and memory abilities, regulate mood, and improve sleep.
Owner:XIAMEN YUANZHIDAO BIOTECHNOLOGY CO LTD

Pediococcus acidilactici TCI550 and application thereof in nerve health care and / or cognition improvement

The invention relates to pediococcus acidilactici, in particular to pediococcus acidilactici TCI550 with the preservation number of DSM34536, and the pediococcus acidilactici TCI550 has the preservation number of DSM34536. In addition, the pediococcus acidilactici TCI550 and / or metabolites thereof can be suitable for preparing a composition for nerve health care and / or cognition improvement.
Owner:BIOFUNCTION SHANGHAI BIOTECH GRP

Biological preparation for relieving intestinal discomfort caused by alcohol as well as preparation method and application of biological preparation

The invention relates to the technical field of functional microbial preparations, in particular to a biological preparation for relieving intestinal discomfort caused by alcohol and a preparation method and application thereof.The main technical scheme is that the biological preparation is prepared from, by weight, 5-20 parts of bacillus coagulans, 10-30 parts of pediococcus pentosaceus, 5-10 parts of lactobacillus rhamnosus and 0-20 parts of saccharomycetes. 0-5 parts of bifidobacterium longum and 0-5 parts of lactococcus lactis. By constructing an alcohol metabolism-intestinal protection dual-function synergistic system, specific florae such as bacillus coagulans, pediococcus pentosaceus and lactobacillus rhamnosus are scientifically compatible with functional components such as inulin and L-cysteine, alcohol is efficiently metabolized, and a carbon source is generated; the technical problems of low metabolic efficiency, weak intestinal protection and serious gastric acid inactivation of a traditional product are comprehensively solved.
Owner:CHANGZHOU AISIKANG BIOMEDICAL CO LTD

Pediococcus acidilactici ZKPa1222, astragalus mongholicus fermentation liquor thereof and application of pediococcus acidilactici ZKPa1222 in aspect of improving immunity

The invention relates to the technical field of probiotics, in particular to pediococcus acidilactici ZKPa1222, astragalus mongholicus fermentation liquor of the pediococcus acidilactici ZKPa1222 and application of the pediococcus acidilactici ZKPa1222 in the aspect of improving immunity, the pediococcus acidilactici ZKPa1222 is preserved in China General Microbiological Culture Collection Center on May 13, 2024, the preservation address is No.3, No.1 yard, Beichen West Road, Chaoyang District, Beijing, the preservation number is CGMCC No.30548, and the preservation number is CGMCC No.30548. The invention further discloses a preparation method of the pediococcus acidilactici ZKPa1222. According to the invention, the pediococcus acidilactici ZKPa1222 is used for directly fermenting the radix astragali extracting solution, so that the fermentation process is simplified, and the fermentation efficiency is improved.
Owner:SHANDONG ZHONGWEI ZHONGKANG BIOTECHNOLOGY CO LTD +1

Pediococcus and culture method and application thereof

The invention discloses pediococcus as well as a culture method and application thereof. The pediococcus is pediococcus 003W, and the preservation number of the pediococcus is CCTCC (China Center for Type Culture Collection) NO: M 2024479. The pediococcus 003W can inhibit growth of escherichia coli and staphylococcus aureus, remove DPPH free radicals and superoxide free radicals and inhibit expression of inflammation-related genes, so that occurrence and development of inflammation are inhibited, and the pediococcus 003W is applicable to preparation of drugs or skin care products and the like with antibacterial, antioxidant or anti-inflammatory functions and can also be prepared into food preservatives, so that the pediococcus 003W has a wide application prospect. Wide application prospects are realized.
Owner:NANJING UNIV OF SCI & TECH

Biological pretreatment method for preparing high-quality veneer and product

The invention discloses a biological pretreatment method for preparing a high-quality veneer and a product, and belongs to the technical field of wood processing. The biological pretreatment method disclosed by the invention comprises the step of soaking raw wood by using a mixed lactic acid bacteria solution, the mixed lactic acid bacteria solution is prepared by mixing lactobacillus plantarum with any one of lactobacillus buchneri, pediococcus acidilactici or lactic streptococci. According to the method, part of chemical components in wood are slightly degraded through lactobacillus fermentation, so that the growth stress and internal stress of the wood are reduced, the wood segment softening effect is achieved, the cutting resistance during rotary cutting or slicing is reduced, the roughness caused by cracks on the back face of the veneer is reduced or reduced, and the appearance quality and surface whiteness of the veneer are improved; and finally, the high-quality rotary-cut or sliced veneer is obtained. According to the scheme provided by the invention, the problems of higher cost, higher energy consumption, wastewater generation, environmental pollution and the like in the traditional treatment method can be effectively solved.
Owner:NANJING FORESTRY UNIV

Pediococcus acidilactici MR21 and application thereof

The invention belongs to the technical field of functional microorganisms, and provides pediococcus acidilactici MR21 and application thereof. The pediococcus acidilactici MR21 provided by the invention is preserved in the China General Microbiological Culture Collection Center (CGMCC) on December 3, 2024, and the preservation number is CGMCC NO. 32896. The pediococcus acidilactici MR21 disclosed by the invention has efficient in-vitro cholesterol removal capacity, excellent safety and remarkable probiotic characteristics, and has the effects of restoring liver functions, reducing liver fat accumulation and regulating expression of fat and cholesterol metabolism related genes by remarkably reducing the content of serum total cholesterol and low-density lipoprotein cholesterol. Therefore, the function of relieving hypercholesterolemia is achieved.
Owner:HAISI FUDE (ZIBO) BIOTECHNOLOGY CO LTD +1

A composite probiotic agent and application thereof in preparation of fermented soy milk

This invention belongs to the field of food fermentation technology, and specifically relates to a compound probiotic agent and its application in the preparation of fermented soy milk. This invention provides a compound probiotic agent composed of *Lactobacillus fermentum* NCPS LF01, *Pediococcus pentosaceus* NCPS PPE01, and *Lactobacillus acidophilus* NCPS LA01 in a volume ratio of 1-2:1:1, and applies this compound probiotic agent to the preparation of soy products, especially fermented soy milk. The beneficial effects of this invention are that fermented soy milk prepared using this compound probiotic agent has a rich flavor, and the total flavonoid and total phenolic content, as well as the in vitro DPPH free radical scavenging rate, are significantly superior to those of ordinary commercially available strains or other strains. In summary, this compound probiotic agent can effectively improve the retention level of active ingredients and antioxidant capacity of fermented soy milk, and has outstanding application value.
Owner:SHANDONG ACADEMY OF AGRICULTURAL SCIENCES +1

Pediococcus acidilactici and application thereof in preparation of medicine for preventing or treating diarrhea of yak calves

The invention discloses pediococcus acidilactici and application thereof in preparation of a medicine for preventing or treating diarrhea of yak calves, and belongs to the technical field of microorganisms. The pediococcus acidilactici is preserved in the China Center for Type Culture Collection, the preservation number is CCTCC NO: M20252012, and the preservation date is September 12, 2025. The strain has remarkable bacteriostatic activity on yak-derived multi-drug-resistant escherichia coli (the accession number of NCBI is PP859186). After the probiotic preparation is orally taken, the yak calf diarrhea induced by escherichia coli can be effectively relieved, the diarrhea rate and the inflammatory factor level are remarkably reduced, the oxidation resistance is improved, the flora structures of intestinal bacteria and fungi are adjusted, and the micro-ecological balance is restored. The invention provides a safe, green and efficient alternative antibody product which is suitable for the plateau yak breeding industry.
Owner:类乌齐县农牧科技推广服务中心(县动物疫病预防控制中心)

Microorganism strain Pediococcus acidilactici tak 589 coccobest as an antimicrobial and antioxidant probiotic

The microorganism strain Pediococcus acidilactici TAK 589 CoccobEst is a new antimicrobial and antioxidant probiotic, CoccobEst inhibits the growth of the enteropathogens L. monocytogenes, E. coli, S. enteritidis, S. typhimurium, S. sonnei, S. aureus, E. faecalis and C. sakazakii, but does not inhibit lactobacilli of natural intestinal microbiota. The strain's antimicrobial properties are enhanced by periplasmic peptidoglycan hydrolases with proteolytic activity. CoccobEst is used as a zootechnieai feed additive to prevent bacterial infections in the gastrointestinal tract of farm animals and pets and to prevent and reduce diarrhea. CoccobEst has highly active antioxidant defense system, increasing the redox activity of glutathione and reducing oxidative stress in cells. Therefore, CoccobEst is used as a food supplement or functional food for humans to prevent bacterial infections of the gastrointestinal tract and to prevent and reduce oxidative stress. In addition, CoccobEst is used as a starter culture in fermentation of vegetables.
Owner:BIOCC OU

Soothing and moisturizing compound as well as preparation method and application thereof

PendingCN119606844ANo longer prone to allergieseliminate discomfortCosmetic preparationsToilet preparationsBiotechnologyQuisqualis indica
The invention relates to the technical field of raw materials of skin care products, and particularly discloses a soothing and moisturizing compound as well as a preparation method and application thereof. The preparation method of the soothing and skin-moistening compound comprises the following steps: 1) mixing rice, cornflower, quisqualis indica, cashew nut and water, heating and extracting to obtain a pre-extract; (2) adding compound bacteria into the pre-extract, and fermenting to obtain a fermented product; the invention discloses a soothing and skin-moistening compound and a preparation method thereof.The soothing and skin-moistening compound has the advantages that the soothing and skin-moistening compound is prepared from compound bacteria of streptomyces cinereorubens fructose fermentation subspecies, fermented lactobacillus mucus and pediococcus pentosaceus, and the soothing and skin-moistening compound is more remarkable in soothing effect.
Owner:MINGYU (GUANGDONG) COSMETICS TECH CO LTD

A multifunctional Pediococcus pentosaccharide and its applications

This invention discloses a multifunctional Pediococcus pentosaccharide strain and its applications. Pediococcus pentosaceus The strain, named *Pediococcus pentosaceus* A07, has the accession number CCTCC NO: M 2025777 and is deposited at the China Center for Type Culture Collection (CCTCC), located at Wuhan University, No. 299 Bayi Road, Wuchang District, Wuhan City, Hubei Province. This strain is capable of degrading nitrite. Using *Pediococcus pentosaceus* A07 to reduce nitrite content can produce high-quality pickles with good flavor and texture, low nitrite content, and high viable cell count. The *Pediococcus pentosaceus* A07 provided by this invention also possesses cholesterol-lowering, zinc protoporphyrin-forming, antibacterial, and antioxidant capabilities, and produces a high biofilm.
Owner:YUNNAN AGRICULTURAL UNIVERSITY

Pediococcus pentosaceus MDL511 and application thereof in preparation of hypolipidemic products

The invention discloses a pediococcus pentosaceus MDL511, which is preserved in the China General Microbiological Culture Collection Center (CGMCC), the preservation number is CGMCC No.35201, the preservation date is July 11, 2025, and the classification name of the strain is pediococcus pentosaceus. The pediococcus pentosaceus MDL511 has the advantages that the preservation number is CGMCC No.35201, the preservation number is CGMCC No.35201, the preservation date is July 11, 2025, and the classification name of the strain is pediococcus pentosaceus. The pediococcus pentosaceus MDL511 disclosed by the invention can be used for remarkably reducing weight gain and fat growth of mice caused by high fat diet, reducing serum cholesterol, LDL-C (Low Density Lipoprotein Cholesterol) and ALT (Atomic Lymphocyte Transferase) levels and remarkably improving hepatic lesions and fat accumulation caused by high fat diet, so that the MDL511 has a blood fat reducing effect, can be used for preparing blood fat reducing products and weight losing products and has a good development prospect.
Owner:ZHE JIANG MAI YA TA JUN JIAN ZHI NENG KE JI YOU XIAN GONG SI +1

Pediococcus acidilactici RM1, separation method and application

The invention relates to the technical field of microbial food fermentation, and particularly discloses pediococcus acidilactici RM1, a separation method and application, and the pediococcus acidilactici RM1 is characterized in that the preservation number of the pediococcus acidilactici RM1 is GDMCC NO.66765; the preservation unit of the pediococcus acidilactici RM1 is Guangdong Microbial Culture Collection Center; the preservation name of the pediococcus acidilactici RM1 is pediococcus acidilactici RM1, and the preservation name of the pediococcus acidilactici RM1 is pediococcus acidilactici RM1. The preservation time of the pediococcus acidilactici RM1 is July 28, 2025. The method has the characteristics of bright red color, difficulty in deterioration during storage and ideal quality and flavor.
Owner:ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES +1